BATM Advanced Communications Ltd.

Tel Aviv Stock Exchange BVC.TA

BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 2.22%

BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) is 2.22% for the year ending December 31, 2023, a -14.66% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 2.61%, a -86.34% change year over year.
  • BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 19.07%, a 80.29% change year over year.
  • BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 10.58%, a 118.97% change year over year.
  • BATM Advanced Communications Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 4.83%, a 102.73% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
Tel Aviv Stock Exchange: BVC.TA

BATM Advanced Communications Ltd.

CEO Mr. Moti Nagar CPA
IPO Date Feb. 27, 2019
Location Israel
Headquarters Neve Ne’eman Ind. Area
Employees 980
Sector Healthcare
Industries
Biotechnology 3D Printing Defense & Military Hardware & Electronics Medical Instruments Plastics Robotics Telehealth
Description

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email